- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/192 - Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
Patent holdings for IPC class A61K 31/192
Total number of patents in this class: 5225
10-year publication summary
|
415
|
486
|
502
|
529
|
535
|
556
|
512
|
525
|
370
|
128
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Genfit | 257 |
79 |
| Galderma Research & Development | 440 |
61 |
| io Therapeutics, Inc. | 112 |
61 |
| Infirst Healthcare Limited | 60 |
50 |
| United Therapeutics Corporation | 291 |
49 |
| Cymabay Therapeutics, Inc. | 105 |
40 |
| The Regents of the University of California | 18943 |
37 |
| Johnson & Johnson Consumer Inc. | 1277 |
35 |
| The General Hospital Corporation | 4517 |
32 |
| Teikoku Seiyaku Co., Ltd. | 188 |
31 |
| Amylyx Pharmaceuticals Inc. | 66 |
29 |
| Hisamitsu Pharmaceutical Co., Inc. | 792 |
27 |
| Allergan, Inc. | 2600 |
23 |
| Selecta Biosciences, Inc. | 190 |
23 |
| Nordiccan A/S | 48 |
22 |
| OCERA Therapeutics, Inc. | 59 |
20 |
| Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1338 |
20 |
| The Johns Hopkins University | 5377 |
19 |
| Canopy Growth Corporation | 270 |
19 |
| Bausch Health Ireland Limited | 751 |
19 |
| Other owners | 4529 |